Analysis of haplotype and coamplification PCR of dystrophin gene and Y-specific gene using PEP-PCR in single fetal cells.
- Author:
Soo Kyung CHOI
1
Author Information
1. Genetic Research Laboratory, Samsung Cheil Hospital College of Medicine, Sungkyunkwan University, Korea.
- Publication Type:Original Article
- Keywords:
Coamplification-PCR;
Muscular dystrophy;
Exon & Haplotype analysis
- MeSH:
Blastomeres;
Chorionic Villi;
Diagnosis;
Dystrophin*;
Embryonic Structures;
Exons;
Fetus;
Genome;
Haplotypes*;
Humans;
Muscular Dystrophies;
Muscular Dystrophy, Duchenne;
Polymerase Chain Reaction*;
Pregnancy;
Preimplantation Diagnosis;
Wills
- From:Journal of Genetic Medicine
1998;2(1):35-40
- CountryRepublic of Korea
- Language:English
-
Abstract:
Duchenne and Becker muscular dystrophy are the major neuromuscular disorders with X-linked recessive inheritance. Preimplantation sex determination has been generally used to avoid pregnancies with these diseases. However, in order to determine if the embryo is normal, carrier or affected regardless of the sex, there is a need for a combined analysis of specific exon on dystrophin gene as well as sex determination of embryo using the same biopsied blastomere. If the exon deletion is not determinable, further diagnosis of carrier or patient can be performed by haplotype analysis. In this study, we applied the primer extension preamplification (PEP) method, which amplifies the whole genome, in 40 cases of single amniocyte and 40 cases of chorionic villus cell. We analysed haplotypes using two (CA)n dinucleotide polymorphic markers located at the end of 5' and 3' region of the dystrophin gene. Exon 46 of dystrophin gene and DYZ3 on chromosome Y were chosen as a target sequence for coamplification PCR. Upon optimizing the conditions, the amplification rates were 91.25% (73/80) for haplotypes (92.5% in amniocyte, 90% in chorionic villus cell) and 88.75% (71/80) for coamplification (85% in amniocyte, 92.5% in chorionic villus cell). The result of the study indicates that haplotypes and coamplification using PEP can be applied to prenatal and preimplantation diagnosis in Duchenne muscular dystrophy making it possible to determine if the fetus is a carrier or an affected one.
